| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 68 | 2019 | 497 | 9.750 |
Why?
|
| Photoaffinity Labels | 32 | 2020 | 86 | 5.330 |
Why?
|
| Torpedo | 62 | 2019 | 169 | 4.530 |
Why?
|
| Receptors, GABA-A | 24 | 2020 | 627 | 4.010 |
Why?
|
| Nicotinic Antagonists | 20 | 2016 | 96 | 3.270 |
Why?
|
| Etomidate | 17 | 2020 | 190 | 3.110 |
Why?
|
| Nicotinic Agonists | 13 | 2016 | 271 | 2.350 |
Why?
|
| Fish Proteins | 4 | 2019 | 46 | 2.110 |
Why?
|
| Barbiturates | 5 | 2017 | 114 | 2.060 |
Why?
|
| Binding Sites | 52 | 2020 | 6114 | 1.900 |
Why?
|
| Propofol | 9 | 2020 | 629 | 1.700 |
Why?
|
| Protein Subunits | 20 | 2020 | 959 | 1.560 |
Why?
|
| Tritium | 16 | 2014 | 745 | 1.430 |
Why?
|
| Diazomethane | 7 | 2018 | 36 | 1.290 |
Why?
|
| Anesthetics, General | 11 | 2020 | 152 | 1.200 |
Why?
|
| Ion Channels | 11 | 2013 | 1056 | 1.130 |
Why?
|
| Azirines | 11 | 2012 | 30 | 1.070 |
Why?
|
| Receptors, GABA | 4 | 2020 | 288 | 1.060 |
Why?
|
| Steroids | 3 | 2020 | 930 | 1.030 |
Why?
|
| Models, Molecular | 23 | 2020 | 5456 | 0.910 |
Why?
|
| Pregnanolone | 2 | 2020 | 62 | 0.830 |
Why?
|
| Electric Organ | 12 | 2000 | 54 | 0.790 |
Why?
|
| Muscle Proteins | 7 | 2016 | 1159 | 0.780 |
Why?
|
| Affinity Labels | 10 | 2013 | 109 | 0.760 |
Why?
|
| Receptors, Cholinergic | 5 | 2005 | 238 | 0.750 |
Why?
|
| Tetracaine | 4 | 2019 | 35 | 0.720 |
Why?
|
| Benzoylcholine | 3 | 2005 | 3 | 0.700 |
Why?
|
| Allosteric Regulation | 12 | 2020 | 408 | 0.690 |
Why?
|
| Protein Structure, Secondary | 10 | 2013 | 1246 | 0.630 |
Why?
|
| Anesthetics, Intravenous | 4 | 2018 | 417 | 0.630 |
Why?
|
| Cell Membrane | 21 | 2012 | 3748 | 0.600 |
Why?
|
| Mephobarbital | 2 | 2014 | 7 | 0.600 |
Why?
|
| Protein Structure, Tertiary | 13 | 2015 | 3846 | 0.590 |
Why?
|
| Anesthetics | 4 | 2020 | 539 | 0.560 |
Why?
|
| Amino Acid Sequence | 30 | 2014 | 13815 | 0.540 |
Why?
|
| Indole Alkaloids | 1 | 2015 | 24 | 0.530 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2015 | 28 | 0.530 |
Why?
|
| Binding, Competitive | 9 | 2020 | 1157 | 0.520 |
Why?
|
| Xenopus laevis | 10 | 2020 | 957 | 0.500 |
Why?
|
| Amino Acids | 8 | 2009 | 1736 | 0.480 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 2020 | 1121 | 0.480 |
Why?
|
| Radioligand Assay | 7 | 2016 | 374 | 0.450 |
Why?
|
| Molecular Sequence Data | 28 | 2014 | 18111 | 0.450 |
Why?
|
| Physostigmine | 1 | 2013 | 53 | 0.440 |
Why?
|
| Cholinergic Agonists | 1 | 2013 | 74 | 0.440 |
Why?
|
| Galantamine | 1 | 2013 | 32 | 0.440 |
Why?
|
| HEK293 Cells | 7 | 2020 | 4204 | 0.430 |
Why?
|
| Embolism | 1 | 2016 | 408 | 0.430 |
Why?
|
| Kinetics | 14 | 2016 | 6473 | 0.420 |
Why?
|
| Animals | 84 | 2020 | 168757 | 0.420 |
Why?
|
| Tubocurarine | 6 | 2006 | 63 | 0.420 |
Why?
|
| Chromatography, High Pressure Liquid | 14 | 2013 | 1572 | 0.420 |
Why?
|
| Peptide Mapping | 8 | 2012 | 263 | 0.400 |
Why?
|
| Craniotomy | 1 | 2016 | 729 | 0.400 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2013 | 238 | 0.390 |
Why?
|
| Xenopus | 10 | 2020 | 712 | 0.380 |
Why?
|
| Benzophenones | 2 | 2007 | 57 | 0.370 |
Why?
|
| Bone Cements | 1 | 2012 | 325 | 0.370 |
Why?
|
| Hypnotics and Sedatives | 3 | 2020 | 1162 | 0.370 |
Why?
|
| Acetylcholine | 7 | 2009 | 621 | 0.350 |
Why?
|
| Chlorpromazine | 1 | 2009 | 111 | 0.350 |
Why?
|
| Diazepam | 2 | 2020 | 205 | 0.350 |
Why?
|
| Azides | 4 | 2012 | 116 | 0.350 |
Why?
|
| Tryptophan | 3 | 2003 | 478 | 0.350 |
Why?
|
| Choice Behavior | 2 | 2006 | 803 | 0.340 |
Why?
|
| Protein Conformation | 12 | 2016 | 4011 | 0.340 |
Why?
|
| Phencyclidine | 4 | 2008 | 61 | 0.330 |
Why?
|
| Photochemistry | 6 | 2013 | 238 | 0.320 |
Why?
|
| Oocytes | 11 | 2018 | 1187 | 0.310 |
Why?
|
| Amphibian Venoms | 3 | 2003 | 5 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2020 | 10943 | 0.280 |
Why?
|
| Neuromuscular Junction | 3 | 2004 | 398 | 0.270 |
Why?
|
| Ion Channel Gating | 7 | 2011 | 437 | 0.270 |
Why?
|
| Ligands | 10 | 2017 | 3282 | 0.270 |
Why?
|
| Anesthesiology | 1 | 2016 | 1060 | 0.270 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2005 | 1660 | 0.270 |
Why?
|
| Tyrosine | 5 | 2009 | 1461 | 0.260 |
Why?
|
| Conotoxins | 3 | 2006 | 20 | 0.260 |
Why?
|
| Octanols | 3 | 2010 | 27 | 0.260 |
Why?
|
| Ethyl Methanesulfonate | 2 | 2002 | 29 | 0.260 |
Why?
|
| Protein Binding | 11 | 2013 | 9386 | 0.260 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 281 | 0.250 |
Why?
|
| Lipid Metabolism | 3 | 2008 | 1889 | 0.250 |
Why?
|
| Agrin | 2 | 2004 | 68 | 0.250 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 10 | 2007 | 1801 | 0.250 |
Why?
|
| Iodine Radioisotopes | 9 | 2008 | 1032 | 0.240 |
Why?
|
| Peptide Fragments | 16 | 2007 | 5097 | 0.240 |
Why?
|
| Protein Structure, Quaternary | 3 | 2016 | 436 | 0.230 |
Why?
|
| Halothane | 1 | 2003 | 206 | 0.230 |
Why?
|
| Neuregulin-1 | 1 | 2004 | 142 | 0.230 |
Why?
|
| Sequence Analysis, Protein | 3 | 2013 | 258 | 0.220 |
Why?
|
| Carbachol | 5 | 2003 | 226 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4462 | 0.220 |
Why?
|
| Synaptic Membranes | 4 | 1996 | 91 | 0.220 |
Why?
|
| Allosteric Site | 3 | 2013 | 103 | 0.220 |
Why?
|
| Diazonium Compounds | 2 | 2001 | 18 | 0.210 |
Why?
|
| Models, Chemical | 4 | 2006 | 626 | 0.200 |
Why?
|
| Neuregulins | 1 | 2000 | 35 | 0.190 |
Why?
|
| Choline | 1 | 2003 | 493 | 0.190 |
Why?
|
| Ethidium | 1 | 2000 | 27 | 0.190 |
Why?
|
| Fluorenes | 2 | 2001 | 160 | 0.190 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2004 | 555 | 0.190 |
Why?
|
| Light | 5 | 2012 | 1374 | 0.190 |
Why?
|
| Patch-Clamp Techniques | 5 | 2016 | 964 | 0.180 |
Why?
|
| Models, Neurological | 2 | 2006 | 1774 | 0.180 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 3848 | 0.180 |
Why?
|
| Cysteine | 2 | 2002 | 874 | 0.180 |
Why?
|
| Ceramides | 1 | 2001 | 199 | 0.180 |
Why?
|
| Nicotine | 2 | 1998 | 681 | 0.180 |
Why?
|
| Cattle | 8 | 2010 | 3922 | 0.180 |
Why?
|
| Promegestone | 1 | 1999 | 9 | 0.170 |
Why?
|
| Recombinant Proteins | 4 | 2016 | 6622 | 0.170 |
Why?
|
| Pulmonary Embolism | 1 | 2012 | 2376 | 0.170 |
Why?
|
| Phenylalanine | 2 | 2006 | 365 | 0.170 |
Why?
|
| Bicuculline | 1 | 2019 | 99 | 0.170 |
Why?
|
| Progesterone Congeners | 1 | 1999 | 42 | 0.170 |
Why?
|
| Muscles | 3 | 2015 | 1614 | 0.170 |
Why?
|
| Hydrolysis | 4 | 2013 | 682 | 0.160 |
Why?
|
| Receptor Aggregation | 1 | 1998 | 80 | 0.160 |
Why?
|
| Anesthetics, Inhalation | 1 | 2003 | 570 | 0.160 |
Why?
|
| Structure-Activity Relationship | 6 | 2020 | 3129 | 0.160 |
Why?
|
| Membrane Lipids | 1 | 1999 | 248 | 0.150 |
Why?
|
| GABA Antagonists | 1 | 2017 | 128 | 0.150 |
Why?
|
| Pregnanediones | 1 | 2017 | 11 | 0.150 |
Why?
|
| Trypsin | 6 | 1998 | 511 | 0.150 |
Why?
|
| Dopamine | 1 | 2004 | 1591 | 0.150 |
Why?
|
| Methionine | 2 | 2012 | 590 | 0.150 |
Why?
|
| Solubility | 4 | 2012 | 1085 | 0.140 |
Why?
|
| Photolysis | 1 | 2016 | 92 | 0.140 |
Why?
|
| Serine Endopeptidases | 6 | 2000 | 1072 | 0.140 |
Why?
|
| GABA Agents | 1 | 2016 | 42 | 0.140 |
Why?
|
| Membrane Proteins | 5 | 2001 | 7880 | 0.140 |
Why?
|
| Protein Isoforms | 2 | 2016 | 1730 | 0.140 |
Why?
|
| Molecular Weight | 7 | 2001 | 2255 | 0.130 |
Why?
|
| Arginine | 1 | 1999 | 944 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 1 | 2001 | 1364 | 0.130 |
Why?
|
| Peptides | 3 | 2004 | 4409 | 0.130 |
Why?
|
| Protein Multimerization | 1 | 2020 | 970 | 0.130 |
Why?
|
| Proadifen | 2 | 2006 | 11 | 0.130 |
Why?
|
| Bungarotoxins | 3 | 2009 | 46 | 0.130 |
Why?
|
| Neurotransmitter Agents | 1 | 2018 | 647 | 0.120 |
Why?
|
| Isoxazoles | 1 | 2016 | 216 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2006 | 459 | 0.120 |
Why?
|
| Ligand-Gated Ion Channels | 1 | 2013 | 8 | 0.120 |
Why?
|
| Humans | 39 | 2020 | 744343 | 0.120 |
Why?
|
| Substance P | 1 | 1994 | 335 | 0.110 |
Why?
|
| Amino Acid Substitution | 3 | 2006 | 1791 | 0.110 |
Why?
|
| Cholinergic Agents | 1 | 2013 | 93 | 0.110 |
Why?
|
| Triazoles | 1 | 2019 | 911 | 0.110 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 2 | 2010 | 43 | 0.110 |
Why?
|
| Sequence Alignment | 3 | 2005 | 2256 | 0.110 |
Why?
|
| Cell Line | 7 | 2009 | 15997 | 0.110 |
Why?
|
| Methylmethacrylate | 1 | 2012 | 44 | 0.110 |
Why?
|
| Myristic Acids | 2 | 1989 | 48 | 0.110 |
Why?
|
| Hodgkin Disease | 1 | 2020 | 1415 | 0.100 |
Why?
|
| Macromolecular Substances | 5 | 1998 | 1454 | 0.100 |
Why?
|
| Mutagenesis | 3 | 2002 | 1266 | 0.100 |
Why?
|
| Cognition | 3 | 2008 | 6770 | 0.100 |
Why?
|
| Mesylates | 2 | 2002 | 36 | 0.100 |
Why?
|
| Alkylation | 3 | 2000 | 86 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3507 | 0.100 |
Why?
|
| Substrate Specificity | 3 | 2012 | 1801 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1850 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2007 | 2839 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2006 | 6669 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 3768 | 0.090 |
Why?
|
| Bupropion | 1 | 2012 | 303 | 0.090 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2003 | 494 | 0.090 |
Why?
|
| Databases, Protein | 1 | 2012 | 383 | 0.090 |
Why?
|
| Ultraviolet Rays | 3 | 2004 | 1060 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 634 | 0.090 |
Why?
|
| Electrophysiology | 2 | 2005 | 1308 | 0.090 |
Why?
|
| Fluorescent Dyes | 6 | 2006 | 1917 | 0.090 |
Why?
|
| Cholates | 1 | 2008 | 3 | 0.090 |
Why?
|
| DNA Mutational Analysis | 3 | 2005 | 4186 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 413 | 0.080 |
Why?
|
| Glutamine | 1 | 1992 | 578 | 0.080 |
Why?
|
| GABA Agonists | 2 | 2006 | 111 | 0.080 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 164 | 0.080 |
Why?
|
| Sequence Analysis | 2 | 1999 | 256 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2020 | 449 | 0.080 |
Why?
|
| Larva | 5 | 2011 | 519 | 0.080 |
Why?
|
| Foreign Bodies | 1 | 2012 | 399 | 0.080 |
Why?
|
| Cyanogen Bromide | 3 | 1992 | 73 | 0.080 |
Why?
|
| Rats | 5 | 2005 | 24260 | 0.080 |
Why?
|
| Cytoplasm | 2 | 1990 | 1539 | 0.080 |
Why?
|
| Pyrenes | 2 | 2001 | 46 | 0.080 |
Why?
|
| Immunoblotting | 3 | 2002 | 1682 | 0.080 |
Why?
|
| Thoracic Vertebrae | 1 | 2012 | 608 | 0.080 |
Why?
|
| Muscimol | 1 | 2006 | 69 | 0.070 |
Why?
|
| Molecular Structure | 3 | 2020 | 1899 | 0.070 |
Why?
|
| Brain | 5 | 2006 | 26385 | 0.070 |
Why?
|
| Myristic Acid | 2 | 2000 | 47 | 0.070 |
Why?
|
| Hypotension | 1 | 2012 | 884 | 0.070 |
Why?
|
| Syndrome | 1 | 2012 | 3251 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 547 | 0.070 |
Why?
|
| Lidocaine | 1 | 2009 | 544 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2016 | 1972 | 0.070 |
Why?
|
| Learning | 2 | 2006 | 1713 | 0.070 |
Why?
|
| Isoflurane | 2 | 2010 | 380 | 0.060 |
Why?
|
| Caveolin 3 | 1 | 2004 | 25 | 0.060 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2004 | 17 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 3772 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2009 | 878 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2008 | 1100 | 0.060 |
Why?
|
| Transcription Factor AP-2 | 1 | 2004 | 82 | 0.060 |
Why?
|
| Stereoisomerism | 3 | 2012 | 624 | 0.060 |
Why?
|
| Caveolins | 1 | 2004 | 104 | 0.060 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2006 | 205 | 0.060 |
Why?
|
| Cross-Linking Reagents | 3 | 2006 | 694 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2012 | 1273 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.060 |
Why?
|
| Epitopes | 1 | 1990 | 2571 | 0.060 |
Why?
|
| Ions | 1 | 2004 | 265 | 0.060 |
Why?
|
| Mollusca | 1 | 2002 | 40 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 1723 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2000 | 2645 | 0.050 |
Why?
|
| Proton-Translocating ATPases | 1 | 2002 | 116 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2003 | 577 | 0.050 |
Why?
|
| Detergents | 1 | 2002 | 230 | 0.050 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2001 | 16 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2000 | 2505 | 0.050 |
Why?
|
| Utrophin | 1 | 2001 | 15 | 0.050 |
Why?
|
| Annexins | 1 | 2001 | 38 | 0.050 |
Why?
|
| Dystroglycans | 1 | 2001 | 60 | 0.050 |
Why?
|
| Porins | 1 | 2001 | 81 | 0.050 |
Why?
|
| Models, Structural | 2 | 1992 | 361 | 0.050 |
Why?
|
| Radiography | 1 | 2012 | 7023 | 0.050 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2000 | 12 | 0.050 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2000 | 24 | 0.050 |
Why?
|
| Drug Antagonism | 1 | 2020 | 50 | 0.050 |
Why?
|
| Flumazenil | 1 | 2020 | 84 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2002 | 475 | 0.050 |
Why?
|
| GABA Modulators | 1 | 2020 | 107 | 0.050 |
Why?
|
| Receptors, Muscarinic | 1 | 2000 | 156 | 0.050 |
Why?
|
| Photochemical Processes | 1 | 2020 | 84 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2012 | 3821 | 0.040 |
Why?
|
| Schwann Cells | 1 | 2000 | 195 | 0.040 |
Why?
|
| Receptor, erbB-3 | 1 | 2000 | 142 | 0.040 |
Why?
|
| Mollusk Venoms | 1 | 1999 | 19 | 0.040 |
Why?
|
| Computers | 1 | 2002 | 612 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 2000 | 2050 | 0.040 |
Why?
|
| Affect | 1 | 2007 | 1476 | 0.040 |
Why?
|
| Freeze Etching | 2 | 1990 | 9 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 462 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2012 | 5985 | 0.040 |
Why?
|
| Zebrafish | 2 | 2020 | 2994 | 0.040 |
Why?
|
| Membranes | 1 | 1999 | 173 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 337 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2006 | 5179 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 936 | 0.040 |
Why?
|
| Presynaptic Terminals | 1 | 2000 | 302 | 0.040 |
Why?
|
| Hexosaminidases | 1 | 1997 | 54 | 0.040 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1997 | 26 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2008 | 6993 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 853 | 0.040 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2009 | 84 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2000 | 927 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2001 | 1202 | 0.040 |
Why?
|
| Pyridines | 1 | 2009 | 2825 | 0.040 |
Why?
|
| Schizophrenia | 2 | 2008 | 6882 | 0.040 |
Why?
|
| Female | 11 | 2020 | 380194 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 12959 | 0.040 |
Why?
|
| Naphthalenes | 1 | 2017 | 194 | 0.040 |
Why?
|
| Amidohydrolases | 1 | 1997 | 169 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 1999 | 400 | 0.040 |
Why?
|
| Cholesterol | 1 | 2006 | 2917 | 0.040 |
Why?
|
| Imidazoles | 1 | 2003 | 1206 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2002 | 1101 | 0.040 |
Why?
|
| Cognition Disorders | 2 | 2008 | 4043 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2001 | 1460 | 0.030 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 1996 | 61 | 0.030 |
Why?
|
| Mice | 7 | 2009 | 81183 | 0.030 |
Why?
|
| Plasmids | 1 | 2000 | 2307 | 0.030 |
Why?
|
| Nerve Net | 1 | 2007 | 2174 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2005 | 4161 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 2088 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2002 | 1425 | 0.030 |
Why?
|
| Dystrophin | 1 | 1996 | 285 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2000 | 1970 | 0.030 |
Why?
|
| Ketamine | 1 | 2020 | 500 | 0.030 |
Why?
|
| Progesterone | 1 | 1999 | 776 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2001 | 985 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2020 | 63114 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2000 | 2025 | 0.030 |
Why?
|
| Models, Animal | 1 | 2020 | 2171 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 2699 | 0.030 |
Why?
|
| Reflex | 2 | 2006 | 365 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 1999 | 1056 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2000 | 2751 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1224 | 0.030 |
Why?
|
| Transfection | 1 | 2000 | 5892 | 0.030 |
Why?
|
| Algorithms | 1 | 2013 | 13881 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2000 | 1451 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 1992 | 668 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1991 | 149 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2969 | 0.020 |
Why?
|
| Cations | 1 | 1991 | 232 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2006 | 689 | 0.020 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 1 | 2010 | 18 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1678 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2000 | 2416 | 0.020 |
Why?
|
| Glutathione Disulfide | 1 | 1990 | 29 | 0.020 |
Why?
|
| Mutation | 3 | 2016 | 29786 | 0.020 |
Why?
|
| Neuropeptides | 1 | 1996 | 942 | 0.020 |
Why?
|
| Internet | 1 | 2002 | 3064 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2006 | 507 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 4644 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8301 | 0.020 |
Why?
|
| Synapses | 2 | 1990 | 1728 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2009 | 91 | 0.020 |
Why?
|
| Myristates | 1 | 1988 | 13 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2009 | 407 | 0.020 |
Why?
|
| Neurons | 1 | 2007 | 9338 | 0.020 |
Why?
|
| Iodoacetamide | 1 | 1987 | 35 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2004 | 4258 | 0.020 |
Why?
|
| Software | 1 | 2002 | 4443 | 0.020 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2008 | 107 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 184 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 3 | 1990 | 9274 | 0.020 |
Why?
|
| Glutathione | 1 | 1990 | 589 | 0.020 |
Why?
|
| Chickens | 1 | 1989 | 865 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1987 | 252 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1996 | 2440 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1991 | 2557 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9648 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2007 | 549 | 0.020 |
Why?
|
| Dansyl Compounds | 1 | 2006 | 20 | 0.020 |
Why?
|
| Sodium | 1 | 1991 | 1623 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2009 | 365 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2000 | 7722 | 0.020 |
Why?
|
| Molecular Probes | 1 | 2007 | 316 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5853 | 0.020 |
Why?
|
| Aziridines | 1 | 2005 | 21 | 0.020 |
Why?
|
| Time Factors | 3 | 2005 | 40075 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4931 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 1681 | 0.020 |
Why?
|
| Temperature | 1 | 1991 | 2206 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2008 | 356 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 977 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 2011 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2004 | 12208 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2008 | 775 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1989 | 1189 | 0.010 |
Why?
|
| Ethanol | 1 | 2010 | 1342 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 3870 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 690 | 0.010 |
Why?
|
| Drug Design | 1 | 2008 | 1076 | 0.010 |
Why?
|
| Play and Playthings | 1 | 2002 | 79 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 2008 | 894 | 0.010 |
Why?
|
| Diphenylhexatriene | 1 | 2001 | 13 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1989 | 2203 | 0.010 |
Why?
|
| Face | 1 | 2007 | 994 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 2007 | 1091 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1989 | 2263 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1989 | 6386 | 0.010 |
Why?
|
| Schizophrenic Psychology | 1 | 2008 | 1678 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1999 | 65 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 163280 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 2838 | 0.010 |
Why?
|
| Amygdala | 1 | 2007 | 1315 | 0.010 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 5708 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 35421 | 0.010 |
Why?
|
| Visual Perception | 1 | 2007 | 1420 | 0.010 |
Why?
|
| Fear | 1 | 2007 | 1440 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 2001 | 381 | 0.010 |
Why?
|
| Consensus | 1 | 2008 | 2959 | 0.010 |
Why?
|
| Psychometrics | 1 | 2008 | 3002 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2000 | 23403 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40561 | 0.010 |
Why?
|
| Phospholipids | 1 | 2001 | 784 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1990 | 19229 | 0.010 |
Why?
|
| Attention | 1 | 2007 | 2400 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3798 | 0.010 |
Why?
|
| Equipment Design | 1 | 2002 | 3582 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1987 | 11366 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 2008 | 3046 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9583 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 7913 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 77449 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1996 | 1117 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4320 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 19905 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1990 | 982 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1988 | 829 | 0.000 |
Why?
|
| RNA | 1 | 1996 | 2749 | 0.000 |
Why?
|
| Base Sequence | 1 | 1996 | 12797 | 0.000 |
Why?
|
| Adult | 2 | 2008 | 214055 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1990 | 6459 | 0.000 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1988 | 1990 | 0.000 |
Why?
|
| United States | 1 | 2008 | 69872 | 0.000 |
Why?
|
| Male | 2 | 2008 | 350118 | 0.000 |
Why?
|